In this issue:
FEF25–75% and FEF75% do not contribute to clinical decision making
Spirometric thresholds for diagnosing smoking-related airflow obstruction
Benzodiazepine and opioid safety in severe respiratory disease
Bronchoscopic lung volume reduction with endobronchial valves
Changes in smoking prevalence since 1980
N-acetylcysteine for COPD exacerbations
Content and organisational aspects of pulmonary rehabilitation programmes
Hospital admissions and exercise capacity decline in COPD
Prednisone in COPD exacerbation requiring ventilatory support
β-blockers and mortality after MI in adults with COPD
Measuring oxygen delivered via nasal cannulae by tracheal sampling
Please login below to download this issue (PDF)